Magenta Therapeutics Shares Surge After Encouraging Data From Blood Cancer Candidate At ASH Meeting

By: via Benzinga
Magenta Therapeutics Inc(NASDAQ: MGTA) highlightedupdated datafrom the ongoing MGTA-117 Phase 1/2 dose-escalation ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.